Trinity Biotech plc
TRIB
NASDAQ·Healthcare·Medical - Specialties·Mkt cap $190.6M
$9.41
▼ -1.98%
P/E
—
Mkt Cap
$190.6M
52-Wk Range
$7.94–$52.50
52-Week Range
$7.94 - $52.50
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 72.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Value
Valuation data unavailable
Momentum
Falling
-53.0% over 3m
Quality
Stable
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying TRIB right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Sep 3, 2026
JUN 16, 2026
Reported EPS of -$0.23 vs -$0.31 consensus (+25.8% surprise).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q2 26
+25.8%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How TRIB stacks vs Medical - Specialties
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.